These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 6307605

  • 1. Ceftriaxone - a new broad-spectrum semisynthetic cephalosporin. In vitro activity against gram-negative bacilli sensitive and resistant to gentamicin.
    Bremner DA.
    Chemotherapy; 1983; 29(4):283-8. PubMed ID: 6307605
    [Abstract] [Full Text] [Related]

  • 2. Susceptibility of gentamicin sensitive and resistant gram negative bacilli to ceftazidime.
    Bremner DA.
    Pathology; 1987 Jul; 19(3):274-6. PubMed ID: 3124067
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
    Baumgärtner M, Grehn M, Wundt W.
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL, Jacobus NV, Tally FP, Gorbach SL.
    Clin Ther; 1983 Jun; 5(6):603-16. PubMed ID: 6313195
    [Abstract] [Full Text] [Related]

  • 5. Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
    Braveny I, Machka K, Elsser R.
    Infection; 1982 Jan; 10(1):45-9. PubMed ID: 6279523
    [Abstract] [Full Text] [Related]

  • 6. [In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime].
    Le Noc P, Bryskier A, Le Noc D.
    Pathol Biol (Paris); 1983 May; 31(5):351-6. PubMed ID: 6312396
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vivo activity of ceftriaxone (Ro 13-9904), a new broad-spectrum semisynthetic cephalosporin.
    Beskid G, Christenson JG, Cleeland R, DeLorenzo W, Trown PW.
    Antimicrob Agents Chemother; 1981 Aug; 20(2):159-67. PubMed ID: 6269487
    [Abstract] [Full Text] [Related]

  • 12. The activity of ceftizoxime in combination with gentamicin against hospital isolates of gentamicin-susceptible and resistant Gram-negative bacteria.
    Penn RL, King JW.
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():51-5. PubMed ID: 6296029
    [No Abstract] [Full Text] [Related]

  • 13. In vitro activity of ceftazidime, cefotaxime and gentamicin against 11,521 clinical isolates of bacteria.
    Steinbakk M, Midtvedt T, Lingaas E, Gardsjord G.
    Acta Pathol Microbiol Immunol Scand B; 1987 Dec; 95(6):337-46. PubMed ID: 3326398
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic and microbial susceptibility studies of ceftriaxone.
    Baumgartner JD, Glauser MP.
    Eur J Clin Microbiol; 1983 Oct; 2(5):501-4. PubMed ID: 6315426
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.